 |
|
|
|
 |
|||
As footnoted regulars know, we tend to pay particularly close attention to filings from companies in the maws of M&A. So we couldn’t help ourselves when we spotted some big pay figures for directors in a proxy filed by Cephalon (CEPH) late last week. That’s because Valeant Pharmaceuticals International (VRX) is giving Cephalon’s shareholders until [...]
With all the rumors, speculation and well-meaning advice swirling around Yahoo (YHOO), we weren’t terribly surprised to find some indications that the board and management were getting a little twitchy. Of course, when corporate titans get twitchy, lawyers usually get busy. And sure enough, Yahoo filed an 8-K on Thursday afternoon disclosing a series of [...]
Though we don’t normally do a lot with proxy fights here at footnoted — the last one we can recall really caring about was the dust-up between Target (TGT) and Pershing Square’s Bill Ackman last year — this revised proxy statement filed late yesterday by Ron Burkle’s Yucaipa Co. over Barnes & Noble (BKS) caught [...]
